Research projects conducted at J-SUPPORT are numbered in the order of approval by the Protocol Review Committee.
Click on the research number for more detailed information on each study.
| Research No. | Study Title |
Status |
| J-SUPPORT 1601 | A scripted video-vignette study to explore the best practice in prognostic disclosure | Completed |
| J-SUPPORT 1602 | TOPICal Steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy : a phase III, randomized, double-blinded trial | Completed |
| J-SUPPORT 1603 | Nurse-led, screening-triggered early specialized palliative care intervention program for advanced lung cancer patients: a randomized controlled trial | Completed |
| J-SUPPORT 1604 | A randomized, double-blind, placebo-controlled phase III trial evaluating olanzapine 5mg combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: J-SUPPORT 1604 | Completed |
| J-SUPPORT 1605 | Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery: a randomized, double-blind, placebo-controlled trial | Completed |
| J-SUPPORT 1701 | Efficacy of prophylactic use of hydrocolloid dressing for hand-foot skin reaction by multi targeted kinase inhibitors: a phase Ⅲ randomized, self-controlled study | Completed |
| J-SUPPORT 1702 | Quality of palliative care for end-of-life cancer patients and retrospective cohort study of unsolved clinical question of palliative care from administrative claims data | Completed |
| J-SUPPORT 1703 | Smartphone-based problem-solving treatment and behavioral activation intervention to reduce fear of recurrence in breast cancer patients-SMILE study：a randomized controlled trial | Completed |
| J-SUPPORT 1704 | A randomized controlled trial of integrated support program for promoting empathietic communication among rapid progressive cancer patients, families and physicians | Completed |
| J-SUPPORT 1901 | A feasibility open trial of the case management to encourage uptake of cancer screening for people with schizophrenia in psychiatric outpatient clinics | Completed |
| J-SUPPORT 1902 | Suicide, other externally caused injuries, and cardiovascular death following a cancer diagnosis: a nationwide population-based study in Japan | Completed |
| J-SUPPORT 1903 | The single-armed confirmatory trial for immediate effectivity and safety of palliative arterial embolization for painful bone metastases. (JIVROSG/J-SUPPORT 1903) | Ongoing |
| J-SUPPORT 2001 | Optimizing smartphone psychotherapy for depression and anxiety among patients with cancer: multiphase optimization strategy [MOST] by using innovative clinical trial system | Completed |
| J-SUPPORT 2002 | Preoperative steroid for enhancing patients` recovery after head and neck cancer surgery with free tissue transfer reconstruction; a phase III, placebo-controlled, randomized, double-blinded study (PreSte-HN) | Ongoing |
| J-SUPPORT 2101 | Randomized Controlled Trial to Develop a Program for Geriatric Assessment and Management by Mobile Applications for Elderly Patients with Advanced and Recurrent Cancer | Ongoing |
| J-SUPPORT 2102 | Interactive assistance via eHealth for small and medium-sized enterprises' employer and health care manager teams on tobacco control | Completed |
| J-SUPPORT 2103 | Ramelteon for prevention of postoperative delirium in delirium high-risk cancer patients.: A randomized, double-blind, placebo-controlled multi-center trial, JORTC-PON02/J-SUPPORT2103/NCCH2103. (RAMP trial) | Ongoing |
| J-SUPPORT 2104 | A Randomized Controlled Trial of a Mobile-based Empathic Communication Support Program to Promote Advance Care Planning Discussion Between Advanced Cancer Patients and Physicians | Completed |
| J-SUPPORT2201 | Feasibility randomized, placebo-controlled trial of efficacy of midazolam as the second-line treatment for dyspnea in patients with advanced cancer | In preparation |
*The users can search clinical studies that are registered and public at clinical study registry sites. It should be noted that the official language of each site depends on the company managing the site.